本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Relmada Therapeutics, Inc.

4.12
-0.0800-1.90%
盤後4.130.0100+0.24%17:43 EDT
成交量:206.98萬
成交額:851.78萬
市值:4.41億
市盈率:-4.43
高:4.17
開:4.15
低:4.06
收:4.20
52周最高:8.00
52周最低:1.47
股本:1.07億
流通股本:7,776.06萬
量比:1.38
換手率:2.66%
股息:- -
股息率:- -
每股收益(TTM):-0.9300
每股收益(LYR):-1.4535
淨資產收益率:-55.66%
總資產收益率:-32.39%
市淨率:2.13
市盈率(LYR):-2.83

資料載入中...

2023/03/13

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/17

重要事件披露

8-K - Current report
2023/01/09

重要事件披露

8-K - Current report
2023/01/05

重要事件披露

8-K - Current report
2022/12/28

重要事件披露

8-K - Current report
2022/12/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/07

重要事件披露

8-K - Current report
2022/11/14

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/10

重要事件披露

8-K - Current report
2022/10/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals